http://orcid.org/0000-0003-0778-8630
References
- Tanaka M, Fernandez-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17(5):738–753.
- Tulla KA, Maker AV. Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas. Langenbecks Arch Surg. 2018;403(2):151–194.
- Ding X, Zhang F, Wang Y. Risk factors for post-ERCP pancreatitis: a systematic review and meta-analysis. Surgeon. 2015;13(4):218–229.
- Hernandez JC, Sendino O, Loras C, et al. Antibiotic prophylaxis not required for endoscopic ultrasound-guided fine-needle aspiration of pancreatic cystic lesions, based on a randomized trial. Gastroenterology. 2020. DOI:10.1053/j.gastro.2020.01.025
- Langerth A, Isaksson B, Karlson BM, et al. ERCP-related perforations: a population-based study of incidence, mortality, and risk factors. Surg Endosc. 2020;34(5):1939–1947.
- Siddiqui AA, Shahid H, Shah A, et al. High risk of acute pancreatitis after endoscopic ultrasound-guided fine needle aspiration of side branch intraductal papillary mucinous neoplasms. Endosc Ultrasound. 2015;4(2):109–114.
- European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67:789–804.
- Heckler M, Brieger L, Heger U, et al. Predictive performance of factors associated with malignancy in intraductal papillary mucinous neoplasia of the pancreas. BJS Open. 2018;2(1):13–24.
- Jang JY, Park T, Lee S, et al. Proposed nomogram predicting the individual risk of malignancy in the patients with branch duct type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2017;266(6):1062–1068.
- Jung W, Park T, Kim Y, et al. Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 mm or less. Br J Surg. 2019;106:1829–1836.
- Arima K, Okabe H, Hashimoto D, et al. The neutrophil-to-lymphocyte ratio predicts malignant potential in intraductal papillary mucinous neoplasms. J Gastrointest Surg. 2015;19(12):2171–2177.
- Ohno R, Kawamoto R, Kanamoto M, et al. Neutrophil to lymphocyte ratio is a predictive factor of malignant potential for intraductal papillary mucinous neoplasms of the pancreas. Biomark Insights. 2019;14:117727191985150.
- Hata T, Mizuma M, Motoi F, et al. Diagnostic and prognostic impact of neutrophil-to-lymphocyte ratio for intraductal papillary mucinous neoplasms of the pancreas with high-grade dysplasia and associated invasive carcinoma. Pancreas. 2019;48(1):99–106.
- Gemenetzis G, Bagante F, Griffin JF, et al. Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2017;266:339–345.
- McIntyre CA, Pulvirenti A, Lawrence SA, et al. Neutrophil-to-lymphocyte ratio as a predictor of invasive carcinoma in patients with intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2019;48(6):832–836.
- Permuth-Wey J, Chen DT, Fulp WJ, et al. Plasma microRNAs as novel biomarkers for patients with intraductal papillary mucinous neoplasms of the pancreas. Cancer Prev Res (Phila). 2015;8(9):826–834.
- Permuth JB, Chen DT, Yoder SJ, et al. Lincing circulating long non-coding RNAs to the diagnosis and malignant prediction of intraductal papillary mucinous neoplasms of the pancreas. Sci Rep. 2017;7(1):10484.
- Akimoto Y, Nouso K, Kato H, et al. Serum N-glycan profiles in patients with intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2015;15(4):432–438.
- Simpson RE, Yip-Schneider MT, Wu H, et al. Circulating thrombospondin-2 enhances prediction of malignant intraductal papillary mucinous neoplasm. Am J Surg. 2019;217(3):425–428.
- Yip-Schneider MT, Simpson R, Carr RA, et al. Circulating leptin and branched chain amino acids-correlation with intraductal papillary mucinous neoplasm dysplastic grade. J Gastrointest Surg. 2019;23(5):966–974.